Vitamin D is required for normal development and bone health.
It is possible that pre-analytical factors may affect the reliability of serum 25-hydroxy vitamin D (25-OH VitD) estimations, and this is important if appropriate clinical interventions are to be made. Hence, it is important to know how pre-analytical factors may affect the results of testing. These factors include sample stability on storage and processing of samples after defrosting. This would be particularly important when analysis is not carried out on a daily basis, and samples are frozen for various lengths of time before estimation. However, to date, there are limited published data on pre-analytical stability of 25-OH VitD in human blood following storage at various temperatures, and for various periods. One study focused on the effects of repeated freeze-thaw cycles. 5 Another study investigated the stability of serum 25-OH VitD levels over time under various sample storage conditions using specimens from only eight patients. 6 A recent study examined the effect of storage at −20°C in the primary collection tube on 25-OH VitD measured by immunoassay. 7 These three studies and other studies ( Table 1) have reported vitamin D to be a stable analyte on storage with no concern about using the quality requirement parameters to estimate the clinical decision thresholds.
However, these studies have been limited either by the small numbers of specimens examined or by the chosen time intervals for storage. Furthermore, no previous study has examined the effects of whether samples were mixed following thawing on 25-OH VitD stability. Vortex mixing is usually used to ensure homogenity of sample following thawing of frozen samples, adding an additional step to the analytical process.
Therefore, the aim of the present study was to assess the stability of 25-OH VitD over a longer period of time and to investigate the effect of vortex mixing on the results of serum 25-OH VitD analysis.
In addition to this, our study aimed to investigate whether the potential changes in the results are clinically significant or not, as this has not been discussed in the previous studies.
| ME THODOLOGY

| Subjects identification
Subjects were recruited randomly for the study from healthy blood donors at King Abdulaziz Medical City, Western Region (National Guard Health Affairs (NGHA)) without regards to vitamin D intake. informed consent form after explaining the purpose of the study, and being assured that it imposed no additional risk. Blood samples were drawn in the phlebotomy area of the laboratory department, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS).
| Specimens collection
All specimens were obtained on a single day. Blood was collected from each subject into two plain (red top) tubes (Becton-Dickinson) using standard venesection technique. Samples with insufficient volume (<8 mL of blood), lipemia, or hemolysis were excluded from the study. Specimens were centrifuged within 1 hour of collection, and the serum separated and aliquoted into 1.0 mL Eppendorf tube with 500 µL of serum. Aliquots were stored at −20°C except for two per subject that were analyzed on the day of collection (day 0). One aliquot was vortexed for 10 seconds, and the second analyzed without vortexing. This procedure was repeated using the stored aliquots on days 1, 2, 3, 4, 5, and 30.
All specimens were measured for total 25-OH VitD concentration 
| Statistical analysis
Statistical analysis was done using SPSS software version 22.
Comparison between group means was performed using paired t tests and across different groups using analysis of variance (ANOVA). A twotailed t test was conducted using an α level of .05 for all statistical tests.
| RE SULTS
The study comprised 31 subjects, with a mean age ± SD of 
| Storage effect
For non-vortex mixed samples, the mean concentration of 25-OH VitD on day 0 was not found to differ significantly on day 1, (P = .654). However, on day 2, the level was significantly higher (P < .001) by 8.50%. This was followed by fluctuations in the mean value on subsequent days, with a slight decrease in the mean on day 3, then a slight increase on day 5, but in all cases, the mean remained significantly higher compared with the mean at day 0 ( Table 2 ). An Similarly, there was a clear difference in the measured concentrations of mean serum 25-OH VitD throughout all storage days for the vortex-mixed serum specimens compared with day 0 mean ( Figure 1 ). There were also significant differences (P < .05) in mean values on day 1, 3, 4, and 15 compared with day 0 ( Table 2 ). An ANOVA of vortex-mixed specimens showed a significant difference in the mean values measured at different times, Wilks' Lambda = 0.48, F = 3.76, P < .05, η 2 = 0.52. Although this indicates that there was a significant trend toward a rise in mean concentration of serum 25-OH VitD compared with day 0 (fresh specimens) over time but this trend was not as apparent as found in the non-vortexed samples (Figure 1 ).
| Mixing (vortexing) effect
Comparing mean levels between non-vortexed and vortexed specimens that were measured on the same day, there were significant differences (P < .05) between them on days 1, 4, 5, and 30, but not on days 0, 2, 3, and 15 (P > .05; Table 2 ).
| D ISCUSS I ON
The The reason for the statistical significant differences in our outcomes compared with previous studies 5-7 is unclear. However, they may result from the larger population sample of our study, and the differences in their local protocols, that is, short time intervals while our protocol has been extended up to 30 days of storage.
Data on the biological variability of analyte concentrations have important implications in clinical chemistry, including assessment of the significance of differences between consecutive results obtained in a single patient. 9 The most widely accepted approach for this purpose is use of the so-called reference change value (RCV) described by Harris and Brown in 1979. 10 
F I G U R E 1 Visual summary of changes in mean concentrations ± SE of 25-OH VitD with and without vortex in each day of analysis
Brescia's study suggests that individual biological variability and analytical variability may affect the variability of 25-OH VitD analysis. 11 They used the DiaSorin LIAISON chemiluminescence immunoassay, which is the same principle to our assay using Architect i2000, to assess single individual, intra-individual biological variability, and analytical variability of 25-OH VitD. 11 They assessed the variation in serial measurements of 25-OH VitD samples, and they concluded that the reference change value (RCV) was 18.0%. 11 Thus, differences in values not exceeding the RCV have no clinical significance on patient outcomes. Our results showed that differences on each subsequent days, for non-vortexed and vortexed specimens, did not exceed the maximum value of 8.88%.
While most of the differences obtained in our study were statistically significant, but at the same time, they were not considered as clinically significant as it did not exceed the recommended RCV for 25-OH VitD of 18%. 11 The allowable total error (TEa) is another quality parameter. It refers to the amount of error that is allowable without invalidating the interpretation of a test result or reaching the clinical decision thresholds. It can be expressed as the maximum allowable bias and imprecision which can be calculated for each analyte. The
TEa for 25-OH Vit D is 46%. It means that the value with a bias of more than 46% from the original value will be significant. This value was calculated by the Advisory Panel of Vitamin D External Quality Assessment Scheme (DEQAS), 12 and it was based on the most common proficiency testing programs. In our study, the maximum difference between intervals, mixing, and without mixing measurements was 8.88%. This value was less than the TEa for 25-OH Vit D.
Therefore, our data show that it is unnecessary to vortex specimens before the measurement of 25-OH VitD. This is a useful prac- In addition to this, our outcomes show that there is no need for <−20°C storage condition (eg, <−75°C freezer) to keep intact samples integrity for testing 25-OH VitD for up to 1 month period.
This study had the limitation that the RCV was obtained using the LIAISON, Diasorin analyzer, alone. Therefore, it is suggested in the future to obtain the RCV on Abbott, Architect i2000 as this was not provided in previous literatures. Another limitation that the study was designed to include healthy subjects only but those with other pathological conditions with extreme 25-OH VitD values were not considered.
| CON CLUS ION
In conclusion, delayed analysis and running samples without vortex- 
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